okredo logo
none title certification

UAB "Via pharma" Finance - revenue, profit

eye icon
More information

EBITDA margin (%)

unlock data icon

Register and

explore Okredo data
More information

EBIT margin (%)

unlock data icon

Register and

explore Okredo data

EBITDA margin (%)

Login to see the data

EBIT margin (%)

Login to see the data

Financial statetment report

Price: €9.90
Premium users: 1.00 credit
Indicator
Turnover (€)
Sales per employee (€)info
Profit before tax (€)
Net Profit (€)
Profit per employee (€)info
Working capital requirementinfo
Debt-to-equity ratioinfo
Total profitability (%)info
Net profitability (%)info
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
EBITDA margin (%)info
EBITDA (€)info
EBIT margin (%)info
EBIT (€)info
2021
258,733
86,244
32,764
27,849
9,283
0.37
0.87
44.94
10.76
96,400
83,995
721
179,674
2022
114,039
38,013
10,310
8,763
2,921
0.83
0.84
51.84
7.68
95,163
79,973
221
174,915
2023
49,866
14,975
-19,824
-19,824
-5,953
1.51
0.81
37.54
-39.75
75,338
60,661
1
135,998
unlock data icon

Register and

explore Okredo data
2023
49,866
14,975
-19,824
-19,824
-5,953
1.51
0.81
37.54
-39.75
75,338
60,661
1
135,998
unlock data icon

Register and

explore Okredo data

2023

Turnover (€)

49,866 €Descended-56 % *

Sales per employee (€)

14,975 €Descended-61 % *

Profit before tax (€)

-19,824 €Descended-292 % *

Net Profit (€)

-19,824 €Descended-326 % *

Profit per employee (€)

-5,953 €Descended-304 % *

Working capital requirement

1.51 Ascended81.93 % *

Debt-to-equity ratio

0.81 Descended-3.57 % *

Total profitability (%)

37.54 %Descended-27.58 % *

Net profitability (%)

-39.75 %Descended-617.58 % *

Equity (€)

75,338 €Descended-21 % *

Amounts Payable And Liabilities (€)

60,661 €Descended-24 % *

Non-current Assets (€)

1 €Descended-100 % *

CurrentAssets (€)

135,998 €Descended-22 % *

*over the last year starting selected period